{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:01:33Z","timestamp":1789441293343,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR080659"],"award-info":[{"award-number":["R01 AR080659"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR077607"],"award-info":[{"award-number":["R01 AR077607"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR070253"],"award-info":[{"award-number":["P30 AR070253"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR072577"],"award-info":[{"award-number":["P30 AR072577"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10067-024-07028-w","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T15:02:32Z","timestamp":1718809352000},"page":"2453-2466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease"],"prefix":"10.1007","volume":"43","author":[{"given":"Rathnam K.","family":"Venkat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Juge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misti","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M. M.","family":"Vanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily N.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina J.","family":"Bade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alene A.","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hae","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Dellaripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Weinblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Shadick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy J.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Dieude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-4618","authenticated-orcid":false,"given":"Jeffrey A.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"key":"7028_CR1","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A (2021) Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev 20:102776. https:\/\/doi.org\/10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun Rev"},{"key":"7028_CR2","doi-asserted-by":"publisher","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","volume":"20","author":"A Conforti","year":"2021","unstructured":"Conforti A, Di Cola I, Pavlych V, Ruscitti P, Berardicurti O, Ursini F, Giacomelli R, Cipriani P (2021) Beyond the joints, the extra-articular manifestations in rheumatoid arthritis. Autoimmun Rev 20:102735. https:\/\/doi.org\/10.1016\/j.autrev.2020.102735","journal-title":"Autoimmun Rev"},{"key":"7028_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","volume":"30","author":"HM Habib","year":"2011","unstructured":"Habib HM, Eisa AA, Arafat WR, Marie MA (2011) Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol 30:217\u2013221. https:\/\/doi.org\/10.1007\/s10067-010-1492-5","journal-title":"Clin Rheumatol"},{"key":"7028_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL (2010) Incidence and mortality of interstitial lung adisease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62:1583\u20131591. https:\/\/doi.org\/10.1002\/art.27405","journal-title":"Arthritis Rheum"},{"key":"7028_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, Murphy J, Cohen M, Raghu G, Brown KK (2011) Rheumatoid arthritis\u2013interstitial lung disease\u2013associated mortality. Am J Respir Crit Care Med 183:372\u2013378. https:\/\/doi.org\/10.1164\/rccm.201004-0622OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7028_CR6","doi-asserted-by":"publisher","first-page":"e003491","DOI":"10.1136\/rmdopen-2023-003491","volume":"9","author":"P-A Juge","year":"2023","unstructured":"Juge P-A, Wemeau L, Ottaviani S, Desjeux G, Zhuo J, Vannier-Moreau V, Flipo R-M, Crestani B, Dieud\u00e9 P (2023) Increased mortality in patients with RA-associated interstitial lung disease: data from a French administrative healthcare database. RMD Open 9:e003491. https:\/\/doi.org\/10.1136\/rmdopen-2023-003491","journal-title":"RMD Open"},{"key":"7028_CR7","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1093\/rheumatology\/keaa836","volume":"60","author":"JA Sparks","year":"2021","unstructured":"Sparks JA, Jin Y, Cho S-K, Vine S, Desai R, Doyle TJ, Kim SC (2021) Prevalence, incidence and cause-specific mortality of rheumatoid arthritis\u2013associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology 60:3689\u20133698. https:\/\/doi.org\/10.1093\/rheumatology\/keaa836","journal-title":"Rheumatology"},{"key":"7028_CR8","doi-asserted-by":"publisher","unstructured":"Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, Williams P, on behalf of ERAS (Early Rheumatoid Arthritis Study) (2010) Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology 49:1483\u20131489.https:\/\/doi.org\/10.1093\/rheumatology\/keq035","DOI":"10.1093\/rheumatology\/keq035"},{"key":"7028_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/resp.13848","volume":"25","author":"HC Kim","year":"2020","unstructured":"Kim HC, Lee JS, Lee EY, Ha Y, Chae EJ, Han M, Cross G, Barnett J, Joseph J, Song JW (2020) Risk prediction model in rheumatoid arthritis-associated interstitial lung disease. Respirology 25:1257\u20131264. https:\/\/doi.org\/10.1111\/resp.13848","journal-title":"Respirology"},{"key":"7028_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/jcm10040874","volume":"10","author":"N Mena-V\u00e1zquez","year":"2021","unstructured":"Mena-V\u00e1zquez N, Rojas-Gimenez M, Romero-Barco CM, Manrique-Arija S, Francisco E, Aguilar-Hurtado MC, A\u00f1\u00f3n-O\u00f1ate I, P\u00e9rez-Albaladejo L, Ortega-Castro R, Godoy-Navarrete FJ, Ure\u00f1a-Garnica I, Velloso-Feijoo ML, Redondo-Rodriguez R, Jimenez-N\u00fa\u00f1ez FG, Panero Lamothe B, Padin-Mart\u00edn MI, Fern\u00e1ndez-Nebro A (2021) Predictors of progression and mortality in patients with prevalent rheumatoid arthritis and interstitial lung disease: a prospective cohort study. JCM 10:874. https:\/\/doi.org\/10.3390\/jcm10040874","journal-title":"JCM"},{"key":"7028_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.rmed.2017.11.013","volume":"134","author":"HM Nurmi","year":"2018","unstructured":"Nurmi HM, Kettunen H-P, Suoranta S-K, Purokivi MK, K\u00e4rkk\u00e4inen MS, Selander TA, Kaarteenaho RL (2018) Several high-resolution computed tomography findings associate with survival and clinical features in rheumatoid arthritis-associated interstitial lung disease. Respir Med 134:24\u201330. https:\/\/doi.org\/10.1016\/j.rmed.2017.11.013","journal-title":"Respir Med"},{"key":"7028_CR12","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, L\u00f8kke A, Bendstrup E, Ellingsen T (2017) A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 76:1700\u20131706. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211138","journal-title":"Ann Rheum Dis"},{"key":"7028_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12931-021-01856-z","volume":"22","author":"M Qiu","year":"2021","unstructured":"Qiu M, Jiang J, Nian X, Wang Y, Yu P, Song J, Zou S (2021) Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. Respir Res 22:264. https:\/\/doi.org\/10.1186\/s12931-021-01856-z","journal-title":"Respir Res"},{"key":"7028_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/resp.12234","volume":"19","author":"D Assayag","year":"2014","unstructured":"Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ (2014) Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology 19:493\u2013500. https:\/\/doi.org\/10.1111\/resp.12234","journal-title":"Respirology"},{"key":"7028_CR15","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1183\/09031936.00092309","volume":"35","author":"EJ Kim","year":"2010","unstructured":"Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE, Collard HR (2010) Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 35:1322\u20131328. https:\/\/doi.org\/10.1183\/09031936.00092309","journal-title":"Eur Respir J"},{"key":"7028_CR16","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A, Frankel SK, Hobbs SB, Huie TJ, Ketzer J, Mannina A, Olson AL, Russell G, Tsuchiya Y, Yunt ZX, Zelarney PT, Brown KK, Swigris JJ (2016) Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 47:588\u2013596. https:\/\/doi.org\/10.1183\/13993003.00357-2015","journal-title":"Eur Respir J"},{"key":"7028_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12890-021-01569-5","volume":"21","author":"MA Nieto","year":"2021","unstructured":"Nieto MA, Rodriguez-Nieto MJ, Sanchez-Pernaute O, Romero-Bueno F, Leon L, Vadillo C, Freites-Nu\u00f1ez DD, Jover JA, \u00c1lvarez-Sala JL, Abasolo L (2021) Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns. BMC Pulm Med 21:205. https:\/\/doi.org\/10.1186\/s12890-021-01569-5","journal-title":"BMC Pulm Med"},{"key":"7028_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.rmed.2017.03.027","volume":"126","author":"ZX Yunt","year":"2017","unstructured":"Yunt ZX, Chung JH, Hobbs S, Fernandez-Perez ER, Olson AL, Huie TJ, Keith RC, Janssen WJ, Goldstein BL, Lynch DA, Brown KK, Swigris JJ, Solomon JJ (2017) High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: relationship to survival. Respir Med 126:100\u2013104. https:\/\/doi.org\/10.1016\/j.rmed.2017.03.027","journal-title":"Respir Med"},{"key":"7028_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12890-016-0269-2","volume":"16","author":"HM Nurmi","year":"2016","unstructured":"Nurmi HM, Purokivi MK, K\u00e4rkk\u00e4inen MS, Kettunen H-P, Selander TA, Kaarteenaho RL (2016) Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes. BMC Pulm Med 16:107. https:\/\/doi.org\/10.1186\/s12890-016-0269-2","journal-title":"BMC Pulm Med"},{"key":"7028_CR20","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/art.42640","volume":"75","author":"G Koduri","year":"2023","unstructured":"Koduri G, Solomon JJ (2023) Identification, monitoring, and management of rheumatoid arthritis\u2013associated interstitial lung disease. Arthritis & Rheumatology 75:2067\u20132077. https:\/\/doi.org\/10.1002\/art.42640","journal-title":"Arthritis & Rheumatology"},{"key":"7028_CR21","doi-asserted-by":"publisher","first-page":"175346662211353","DOI":"10.1177\/17534666221135314","volume":"16","author":"K Kim","year":"2022","unstructured":"Kim K, Woo A, Park Y, Yong SH, Lee SH, Lee SH, Leem AY, Kim SY, Chung KS, Kim EY, Jung JY, Kang YA, Kim YS, Park MS (2022) Protective effect of methotrexate on lung function and mortality in rheumatoid arthritis\u2013related interstitial lung disease: a retrospective cohort study. Ther Adv Respir Dis 16:175346662211353. https:\/\/doi.org\/10.1177\/17534666221135314","journal-title":"Ther Adv Respir Dis"},{"key":"7028_CR22","doi-asserted-by":"publisher","first-page":"9184","DOI":"10.1038\/s41598-021-88734-2","volume":"11","author":"E Cano-Jim\u00e9nez","year":"2021","unstructured":"Cano-Jim\u00e9nez E, V\u00e1zquez Rodr\u00edguez T, Mart\u00edn-Robles I, Castillo Villegas D, Juan Garc\u00eda J, Bollo De Miguel E, Robles-P\u00e9rez A, Ferrer Galv\u00e1n M, Mouronte Roibas C, Herrera Lara S, Bermudo G, Garc\u00eda Moyano M, Rodr\u00edguez Portal JA, Sellar\u00e9s Torres J, Narv\u00e1ez J, Molina-Molina M (2021) Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis. Sci Rep 11:9184. https:\/\/doi.org\/10.1038\/s41598-021-88734-2","journal-title":"Sci Rep"},{"key":"7028_CR23","doi-asserted-by":"publisher","first-page":"152004","DOI":"10.1016\/j.semarthrit.2022.152004","volume":"55","author":"N Chen","year":"2022","unstructured":"Chen N, Diao C-Y, Gao J, Zhao D-B (2022) Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: clinical features, biomarkers, and treatment options. Semin Arthritis Rheum 55:152004. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152004","journal-title":"Semin Arthritis Rheum"},{"key":"7028_CR24","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10067-018-4382-x","volume":"38","author":"Q Fu","year":"2019","unstructured":"Fu Q, Wang L, Li L, Li Y, Liu R, Zheng Y (2019) Risk factors for progression and prognosis of rheumatoid arthritis\u2013associated interstitial lung disease: single center study with a large sample of Chinese population. Clin Rheumatol 38:1109\u20131116. https:\/\/doi.org\/10.1007\/s10067-018-4382-x","journal-title":"Clin Rheumatol"},{"key":"7028_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1164\/rccm.202201-0124OC","volume":"207","author":"JV Pugashetti","year":"2023","unstructured":"Pugashetti JV, Adegunsoye A, Wu Z, Lee CT, Srikrishnan A, Ghodrati S, Vo V, Renzoni EA, Wells AU, Garcia CK, Chua F, Newton CA, Molyneaux PL, Oldham JM (2023) Validation of proposed criteria for progressive pulmonary fibrosis. Am J Respir Crit Care Med 207:69\u201376. https:\/\/doi.org\/10.1164\/rccm.202201-0124OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7028_CR26","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner R-G, Schlenker-Herceg R, Brown KK (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381:1718\u20131727. https:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"key":"7028_CR27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/resp.14231","volume":"27","author":"KK Brown","year":"2022","unstructured":"Brown KK, Inoue Y, Flaherty KR, Martinez FJ, Cottin V, Bonella F, Cerri S, Danoff SK, Jouneau S, Goeldner R, Schmidt M, Stowasser S, Schlenker-Herceg R, Wells AU (2022) Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases. Respirology 27:294\u2013300. https:\/\/doi.org\/10.1111\/resp.14231","journal-title":"Respirology"},{"key":"7028_CR28","doi-asserted-by":"publisher","first-page":"152187","DOI":"10.1016\/j.semarthrit.2023.152187","volume":"60","author":"H Farquhar","year":"2023","unstructured":"Farquhar H, Beckert N, Beckert L, Edwards A, Matteson E, Frampton C, Stamp L (2023) Survival of adults with rheumatoid arthritis associated interstitial lung disease - a systematic review and meta-analysis. Semin Arthritis Rheum 60:152187. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152187","journal-title":"Semin Arthritis Rheum"},{"key":"7028_CR29","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1093\/rheumatology\/kead027","volume":"62","author":"SH Chang","year":"2023","unstructured":"Chang SH, Lee JS, Ha Y-J, Kim MU, Park CH, Lee JS, Kim J-W, Chung SW, Pyo JY, Lee SW, Kang EH, Lee Y-A, Park Y-B, Choe J-Y, Lee EY (2023) Lung function trajectory of rheumatoid arthritis\u2013associated interstitial lung disease. Rheumatology 62:3014\u20133024. https:\/\/doi.org\/10.1093\/rheumatology\/kead027","journal-title":"Rheumatology"},{"key":"7028_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/jpm6010002","volume":"6","author":"E Karlson","year":"2016","unstructured":"Karlson E, Boutin N, Hoffnagle A, Allen N (2016) Building the partners healthcare biobank at partners personalized medicine: informed consent, return of research results, recruitment lessons and operational considerations. JPM 6:2. https:\/\/doi.org\/10.3390\/jpm6010002","journal-title":"JPM"},{"key":"7028_CR31","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/acr.20184","volume":"62","author":"KP Liao","year":"2010","unstructured":"Liao KP, Cai T, Gainer V, Goryachev S, Zeng-treitler Q, Raychaudhuri S, Szolovits P, Churchill S, Murphy S, Kohane I, Karlson EW, Plenge RM (2010) Electronic medical records for discovery research in rheumatoid arthritis. Arthritis Care Res 62:1120\u20131127. https:\/\/doi.org\/10.1002\/acr.20184","journal-title":"Arthritis Care Res"},{"key":"7028_CR32","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1093\/rheumatology\/keaa198","volume":"59","author":"S Huang","year":"2020","unstructured":"Huang S, Huang J, Cai T, Dahal KP, Cagan A, He Z, Stratton J, Gorelik I, Hong C, Cai T, Liao KP (2020) Impact of ICD10 and secular changes on electronic medical record rheumatoid arthritis algorithms. Rheumatology 59:3759\u20133766. https:\/\/doi.org\/10.1093\/rheumatology\/keaa198","journal-title":"Rheumatology"},{"key":"7028_CR33","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Hobbs K, Huizinga TWJ, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, M\u00e9nard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsk\u00fd J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"7028_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/rheumatology\/keq263","volume":"50","author":"CK Iannaccone","year":"2011","unstructured":"Iannaccone CK, Lee YC, Cui J, Frits ML, Glass RJ, Plenge RM, Solomon DH, Weinblatt ME, Shadick NA (2011) Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women\u2019s Hospital Rheumatoid Arthritis Sequential Study. Rheumatology 50:40\u201346. https:\/\/doi.org\/10.1093\/rheumatology\/keq263","journal-title":"Rheumatology"},{"key":"7028_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324. https:\/\/doi.org\/10.1002\/art.1780310302","journal-title":"Arthritis Rheum"},{"key":"7028_CR36","doi-asserted-by":"publisher","first-page":"152312","DOI":"10.1016\/j.semarthrit.2023.152312","volume":"64","author":"P-A Juge","year":"2024","unstructured":"Juge P-A, Hayashi K, McDermott GC, Vanni KMM, Kowalski E, Qian G, Bade K, Saavedra A, Dieud\u00e9 P, Dellaripa PF, Doyle TJ, Sparks JA (2024) Effectiveness and tolerability of antifibrotics in rheumatoid arthritis-associated interstitial lung disease. Semin Arthritis Rheum 64:152312. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152312","journal-title":"Semin Arthritis Rheum"},{"key":"7028_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.acra.2009.07.016","volume":"17","author":"GR Washko","year":"2010","unstructured":"Washko GR, Lynch DA, Matsuoka S, Ross JC, Umeoka S, Diaz A, Sciurba FC, Hunninghake GM, San Jos\u00e9 Est\u00e9par R, Silverman EK, Rosas IO, Hatabu H (2010) Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 17:48\u201353. https:\/\/doi.org\/10.1016\/j.acra.2009.07.016","journal-title":"Acad Radiol"},{"key":"7028_CR38","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJMoa1007285","volume":"364","author":"GR Washko","year":"2011","unstructured":"Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Est\u00e9par RSJ, Lynch DA, Brehm JM, Andriole KP, Diaz AA, Khorasani R, D\u2019Aco K, Sciurba FC, Silverman EK, Hatabu H, Rosas IO (2011) Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 364:897\u2013906. https:\/\/doi.org\/10.1056\/NEJMoa1007285","journal-title":"N Engl J Med"},{"key":"7028_CR39","doi-asserted-by":"publisher","first-page":"e638","DOI":"10.1016\/S2665-9913(21)00140-5","volume":"3","author":"TY-T Hsu","year":"2021","unstructured":"Hsu TY-T, D\u2019Silva KM, Patel NJ, Wang J, Mueller AA, Fu X, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Cook C, Choi HK, Zhang Y, Gravallese EM, Wallace ZS, Sparks JA (2021) Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study. The Lancet Rheumatology 3:e638\u2013e647. https:\/\/doi.org\/10.1016\/S2665-9913(21)00140-5","journal-title":"The Lancet Rheumatology"},{"key":"7028_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000360229","volume":"65","author":"DS Nagin","year":"2014","unstructured":"Nagin DS (2014) Group-based trajectory modeling: an overview. Ann Nutr Metab 65:205\u2013210. https:\/\/doi.org\/10.1159\/000360229","journal-title":"Ann Nutr Metab"},{"key":"7028_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"key":"7028_CR42","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144","journal-title":"J Am Stat Assoc"},{"key":"7028_CR43","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.39971","volume":"69","author":"JA Zamora-Legoff","year":"2017","unstructured":"Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL (2017) Progressive decline of lung function in rheumatoid arthritis\u2013associated interstitial lung disease. Arthritis & Rheumatology 69:542\u2013549. https:\/\/doi.org\/10.1002\/art.39971","journal-title":"Arthritis & Rheumatology"},{"key":"7028_CR44","doi-asserted-by":"publisher","unstructured":"McDermott GC, Hayashi K, Yoshida K, Juge P-A, Moll M, Cho MH, Doyle TJ, Kinney GL, Dellaripa PF, Wallace ZS, Regan EA, Hunninghake GM, Silverman EK, Ash SY, Estepar RSJ, Washko GR, Sparks JA (2023) Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers. Rheumatology kead645. https:\/\/doi.org\/10.1093\/rheumatology\/kead645","DOI":"10.1093\/rheumatology\/kead645"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07028-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07028-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07028-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T08:17:21Z","timestamp":1721809041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07028-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7028"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07028-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Juge has performed consultancy for Galapagos and has received payment\/honoraria from Boehringer Ingelheim and Novartis, all unrelated to this study. Dr. Weinblatt has performed consultancy for Abbvie, Amgen, Aclaris, Aqtual, Bristol Myers Squibb, Glaxo Smith Kline, Johnson and Johnson, Eli Lilly, Novartis, Prometheus, Pfizer, Rani, Revolo, Sanofi, Scipher, Sci Rhom, Set Point, and Biohaven, and holds stock in Canfite, Inmedix, and Scipher, all unrelated to this study. Dr. Doyle has been part of a clinical trial funded by Genentech unrelated to this study. Dr. Dieude has performed consultancy for Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Abbvie, Pfizer, Novartis, and Galapagos, and has participated on a data safety monitoring\/advisory board for Bristol Myers Squibb, all unrelated to this study. Dr. Sparks has performed consultancy for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Optum, Pfizer, ReCor, Sobi, and UCB unrelated to this study. The funders had no role in the decision to publish or preparation of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}